BUY Emcure Pharmaceuticals — Arun Kumar Mantri, 10 Sept 2026

byArun Kumar MantriHorizon: NA (inferred Swing (≤2wk))10 Sept 2026via CNBC Awaaz.

Entry₹1,965Inferred

Target₹2,055

Stop loss₹1,959-0.31% risk

Exit₹1,95911 Sept 2026, 9:20 am

Stop-loss hit-0.31%

Follow Arun Kumar Mantri for new calls(26% target hit, 145 closed calls)Get alerts Watch EMCURE for new buy/sell callsGet alerts See 5 active Swing calls on EMCURE See 312 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Sept 2026

4 supporting2 neutral0 opposing

Supports the BUY call (4)

4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·11 Sept · today

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · 3d ago

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 6d ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 2mo ago

Neutral / worth noting (2)

Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday

NewsEt-Markets·6 Sept · 4d ago

Coal India, Emcure Pharma, Finolex Cables, GIC, Gulf Oil Lubricants Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·3 Sept · 1w ago

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Emcure Pharmaceuticals Limited — Arun Kumar Mantri

AI Assessment